Today, affiliates of CD&R and TPG Global, LLC (together, the “Sponsors”) made a proposal to acquire all of the outstanding shares of Covetrus’ common stock that are not owned by the Sponsors or their affiliates for cash consideration of $21.00 per share. (Read CD&R’s Schedule 13D amendment HERE.)

Our Board and management team are currently reviewing the offer as we look for ways to help Covetrus continue to grow and better serve our customers, employees, suppliers, business partners and shareholders. There can be no assurance that any transaction will be consummated, but regardless of the ultimate outcome, this is a vote of confidence in our future from our largest shareholder, CD&R. As always, we remain focused on empowering veterinarians and driving better care for animals across the globe.